Turn Therapeutics Inc.
Turn Therapeutics Inc. is listed today as Turn Therapeutics Inc.: market value, financials and filings are on its company page.
Funding rounds
0 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Aug 2026 | $2 M | Private placement after listing | Under $2 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Turn Therapeutics Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2026).
SEC Form D · Aug 2026
The industry group it chose in its notices: Biotechnology.
SEC Form D · Aug 2026
That is all the official record says: Turn Therapeutics Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of Turn Therapeutics Inc. are on record.
Investors#
No investor of Turn Therapeutics Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.
Largest shareholders today
Institutions holding Turn Therapeutics Inc. shares, as of Sep 30, 2026.
- Vanguard Capital Management LLC$6 M1.39%
- BlackRock, Inc.$4 M0.85%
- SteelPeak Wealth, LLC$4 M0.82%
- Ieq Capital, LLC$3 M0.74%
- Millennium Management LLC$2 M0.55%
- Geode Capital Management, LLC$2 M0.52%
- Morgan Stanley$2 M0.46%
- DDFG, Inc$2 M0.36%
- Susquehanna International Group, LLP$1 M0.31%
- HRT Financial LP$1 M0.19%
- Vanguard Fiduciary Trust Co$1 M0.12%
- Aaron Wealth Advisors LLC$0 M0.11%
- Northern Trust Corp$0 M0.10%
- Tamar Securities, LLC$0 M0.10%
- Goldman Sachs Group Inc$0 M0.09%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Bradley Burnam | Executive officer | Aug 2026 |
| Neilesh Shailesh Ghodadra | Executive officer | Aug 2026 |
| Zuraiz Chaudhary | Executive officer | Aug 2026 |
| Andrew William Gengos | Director | Aug 2026 |
| Arthur F Golden | Director | Aug 2026 |
| Bradley Burnam | Director | Aug 2026 |
| Kent F Kester | Director | Aug 2026 |
| Martin William Dewhurst | Director | Aug 2026 |
| Neilesh Shailesh Ghodadra | Director | Aug 2026 |
Went public since 2025. Its SEC number is that of a company listed on a stock exchange.